Streetbeat News

Stock Prices

MRSN

Mersana Therapeutics' stock price increased following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 8:00 pm

HY

Hyster-Yale Materials Handling's stock is trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:59 pm

CEG

Keybanc analyst Sangita Jain has upgraded Constellation Energy (NASDAQ:CEG) from Sector Weight to Overweight and set a new price target of $190.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:58 pm

BTCUSD

El Salvador's President Nayib Bukele reaffirmed the country's commitment to holding its Bitcoin investments, despite being up over 40% from its purchase price. Bukele's stance comes amid criticism and concerns over the country's financial strategies, including challenges from the IMF. However, Bitcoin's rising valuation has positively impacted El Salvador's sovereign bond ratings. Bukele's support for Bitcoin has garnered attention and support from the cryptocurrency community, including exchanges like Kraken.

Portfolio Pulse from Ivan Crnogatić

February 28, 2024 | 7:58 pm

NRDY

Nerdy's stock is trading lower following the release of their Q4 financial results and the issuance of Q1 revenue guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:55 pm

SNOW

SPRX

Snowflake, Inc. (SNOW) was trading near flat as it approached its Q4 earnings, with Citigroup analyst Tyler Radke maintaining a Buy rating and raising the price target from $255 to $290. Snowflake's stock appears bullish from a technical analysis perspective. Spear Invest ETF (SPRX), which holds Snowflake as a major investment, offers diversification and targets long-term capital growth, having risen about 64% over the last twelve months and 10.5% year-to-date.

Portfolio Pulse from Melanie Schaffer

February 28, 2024 | 7:54 pm

VFS

VinFast Auto's stock price increased following Chardan Capital's decision to raise its price target from $11 to $13.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:51 pm

GSK

PPH

PTEU

A group of 11 European stocks, dubbed 'Granolas' by Goldman Sachs, has outperformed the global market with lower volatility and higher yields compared to 'The Magnificent Seven' tech stocks. These companies, operating in sectors like healthcare, pharmaceuticals, luxury goods, consumer staples, industrial manufacturing, and software technology, offer advantages such as lower valuation multiples, higher dividend yields, and less volatility. Notable companies include GSK, Roche, ASML, Nestle, Novo Nordisk, Novartis, L'Oreal, LVMH, AstraZeneca, Sanofi, and SAP. For investors interested in these stocks, ETFs like the VanEck Pharmaceutical ETF (PPH) and Pacer Trendpilot European Index ETF (PTEU) are recommended.

Portfolio Pulse from Stjepan Kalinic

February 28, 2024 | 7:43 pm

ADIL

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares surged after the company announced receiving a new patent for AD04, aimed at treating opioid use disorder. The patent, awarded by the United States Patent and Trademark Office, covers AD04's ability to target the serotonin transporter gene. CEO Cary Claiborne highlighted the patent's importance for the company's Intellectual Property portfolio and AD04's potential in treating various drug dependencies. Following the announcement, ADIL's stock price increased by 117.5% to $1.89, with trading volume significantly exceeding the 100-day average.

Portfolio Pulse from Erica Kollmann

February 28, 2024 | 7:43 pm

MS

Morgan Stanley is reportedly considering the inclusion of spot Bitcoin ETFs on its extensive brokerage platform, according to sources cited by Coindesk. This move could significantly broaden access to Bitcoin for the firm's clients.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 7:40 pm